Cover · Chokepoint of the week
One wafer. Seven tickers. Zero substitutes.
AXTI's indium phosphide line has an 8-week backlog. Every public ticker downstream — and what their Q1 margin tells you about allocation priority.
AXTIsource
COHR98.2%
MRVL72.4%
NVDAindir.
METAindir.